When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Unlike other players in its space, biotech royalty aggregator XOMA Corporation (XOMA) focuses on early and mid-stage assets requiring smaller capital commitments.
Since the company’s pivot to royalty aggregation in 2017, it has accumulated over 70 programs, yet none have reached commercial stage.
With its first-filed BLA carrying an August 18, 2021 PDUFA date, twelve data readouts over the ensuing year, and little debt, XOMA merited further investigation.
A full investment analysis and recommendation follows in the paragraphs below.